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AbstrACt
Objective Bariatric surgery is an effective method of 
weight reduction and has been associated with acute 
kidney injury (AKI) as a perioperative event. However, the 
long-term effects of the weight reduction after surgery on 
AKI are unknown. The objective of this study is to quantify 
the association of bariatric surgery with later risk of AKI.
Design This study uses a propensity score-matched 
cohort of patients from the UK Clinical Practice Research 
Datalink database with and without bariatric surgery to 
compare rates of AKI episodes derived from linkage to the 
Hospital Episode Statistics.
setting England, UK.
Participants We included 2643 patients with bariatric 
surgery and 2595 patients without.
results Results were compatible with an increased risk 
of AKI in the first 30 days following surgery compared 
with patients without surgery, but AKI incidence was 
substantially decreased in patients with bariatric surgery 
during long-term follow-up (rate ratio 0.37, 95% CI 0.23 
to 0.61) even after accounting for chronic kidney disease 
status at baseline. Over the whole period of follow-up, 
bariatric surgery had a net protective effect on risk of AKI 
(rate ratio 0.45, 95% CI 0.28 to 0.72).
Conclusions Bariatric surgery was associated with 
protective effects on AKI incidence during long-term 
follow-up. While the risk of AKI may be increased within 
the first 30 days, the net effect seen was beneficial.
IntrODuCtIOn 
The proportions of overweight and obese 
adults in England in 2014 are estimated to 
be 61.7% and 25.6%, respectively, and are 
increasing over time.1 Obesity is associated 
with serious health consequences including 
type 2 diabetes mellitus (T2DM), cardiovas-
cular diseases, cancers and chronic kidney 
disease (CKD).2–4 Bariatric surgery has been 
shown to be a highly effective intervention 
for achieving weight loss and reducing the 
burden of comorbidities, such as T2DM, meta-
bolic syndrome and hypertension.5 6 A recent 
observational study on recipients of bariatric 
surgery from the UK confirmed sustained 
weight loss as well as resolution of T2DM and 
hypertension over a period of 4 years.7 
Acute kidney injury (AKI) is defined as a 
sudden (over hours or days) drop in kidney 
function characterised by increased serum 
creatinine and/or reduced urine output. 
AKI has been linked to increased in-hospital 
mortality, length of hospital stay and subse-
quent development of CKD.8 While T2DM, 
CKD and obesity have been described as risk 
factors for AKI, it can also be precipitated 
by nephrotoxic drugs, surgical interventions 
and sepsis.8–10 AKI has been described as a 
short-term complication of bariatric surgery, 
stemming from rhabdomyolysis.10–16 In addi-
tion, AKI has been linked to nephrolithiasis, 
which can develop over time after Roux-en-Y 
gastric bypass surgery.11 17 To the best of our 
knowledge, no studies have been published 
strengths and limitations of this study
 ► This study uses high-quality data from linked da-
tabases in England (Clinical Practice Research 
Datalink and Hospital Episode Statistics) to describe 
long-term effects of bariatric surgery on acute kid-
ney injury (AKI) for the first time.
 ► Data are captured prospectively and continuously, 
thus allowing follow-up of patients over long-time 
periods.
 ► Outcome measures are obtained with standardised 
International Classification of Diseases, 10th 
Revision codes, which have been shown to accu-
rately identify AKI, but do not allow grading of se-
verity and may therefore underestimate true AKI 
incidence.
 ► Only AKI events recorded during a hospital admis-
sion were included in the analysis likely represent-
ing the more serious events of AKI.
 ► The study population was mostly female, of middle 
age and had a history of type 2diabetes mellitus. 
Thus, the results might not be applicable for other 
groups suffering from obesity such as adolescents.
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examining the long-term effects of bariatric surgery on 
AKI.
In this study, we investigate the long-term effects of 
bariatric surgery on AKI to see whether the expected 
reduction in body mass index (BMI) has any impact on 
subsequent renal health. We used routinely collected elec-
tronic health record data from primary and secondary 
care. For this, we conducted a matched cohort study 
using prospectively collected data from patients in the UK 
Clinical Practice Research Datalink (CPRD).
MethODs
Patient and public involvement
Patients or public were not involved in the design or 
conduct of the study.
study design
We undertook a matched cohort study using prospectively 
collected data from CPRD patients registered before 31 
December 2014 linked to the Hospital Episodes Statis-
tics (HES) database to investigate long-term effects of 
bariatric surgery on AKI.
Data source
The CPRD database contains anonymised, routinely 
collected data on approximately 10 million patients in 
participating primary care practices in the UK, including 
demographic characteristics, current and previous diag-
noses, prescribing, test results and lifestyle factors. Diag-
noses, signs and symptoms are recorded using Read 
codes.18 Patients are broadly representative of the UK 
population and the data have been validated for a wide 
range of outcomes.19–21 The HES database contains 
patient data from hospital admissions to English hospitals 
within the National Health Service.22 For each hospital 
admission, the diagnoses are recorded using standardised 
codes of the International Classification of Diseases, 10th 
Revision (ICD-10).23 24 Data from 70% of CPRD practices 
in England have been linked at patient level with HES 
admission data, thus allowing the combined analysis of 
data from primary and acute hospital care for a subset of 
patients.19
Cohort design and propensity matching
A detailed description of how the cohort was constructed 
is described elsewhere.7 In brief, records of patients who 
underwent bariatric surgery (n=3882) between 1997 and 
2015 were matched to individuals who did not undergo 
surgery (n=3882) using propensity scores.
Study population matching and the propensity score 
incorporated information on age, sex, calendar period, 
history of T2DM, hypertension, coronary heart disease, 
cerebrovascular disease, peripheral vascular disease, 
other atheroma, use of insulin, use of oral antidiabetic 
medication, use of statins, smoking status and alcohol 
consumption.
Patients with bariatric surgery were identified using Read 
codes for surgery in the CPRD database (online supple-
mentary appendix S1) and were included in the study if 
they had been registered in the CPRD ≥12 months prior 
to the intervention. We excluded those with a record of 
prior bariatric surgery reversal.
For the comparison group, the inclusion criteria were 
to have at least one BMI measurement ≥40 kg/m2 during 
their CPRD registration, which could span 10 years or 
more, ≥12 months of follow-up prior to the index date 
in the database, and no prior record of bariatric surgery 
or bariatric surgery reversal. Based on this, it is therefore 
possible that the BMI recorded closest to the index date 
was lower than 40 kg/m².
The study sample was restricted to eligible patients 
registered at practices linked to the HES database and 
information on AKI events was obtained, resulting in a 
final cohort comprising 2643 patients who underwent 
bariatric surgery, and 2595 patients who did not.
Follow-up started on the day of surgery for those with 
bariatric surgery, and for the comparison group who did 
not undergo bariatric surgery, on the surgery date of 
their matched case. Patient records were censored at the 
earliest of: AKI, death, leaving the practice, latest data 
collection from current practice or end of linkage period 
to the HES database.
Outcomes and covariates
The primary outcome of this study was the incidence rate 
of the first AKI episode during follow-up in patients with 
and without bariatric surgery. AKI episodes were obtained 
from the HES database using ICD-10 codes: N17.0 (‘acute 
kidney failure with tubular necrosis’), N17.1 (‘acute renal 
failure with acute cortical necrosis), N17.2 (‘acute renal 
failure with medullary necrosis’), N17.8 (‘other acute 
renal failure’), N17.9 (‘acute kidney failure, unspeci-
fied’) and N19 (‘unspecified kidney failure’). In this 
cohort, events coded with N17.1, N17.2 and N17.8 were 
not found. AKI events that occurred before the start of 
follow-up were recorded as a binary variable ‘history of 
AKI’, while AKI events occurring during follow-up were 
used to analyse AKI incidence.
Recorded serum creatinine values from the CPRD data-
base were not routinely standardised with isotope dilu-
tion mass spectrometry before 2013. Thus, we assumed 
all measurements to be unstandardised and multiplied 
the creatinine measures with the factor 0.95 before calcu-
lating the estimated glomerular filtration rate (eGFR) 
using the ‘Chronic Kidney Disease Epidemiology Collab-
oration’ equation.25 Ethnicity was not considered in 
the eGFR calculation due to incomplete recording in 
the database and the low proportion of Afro-Caribbean 
people in the population. CKD stages were defined 
according to eGFR values in mL/min/1.73 m2 according 
to current guidelines26: eGFR ≥60=no known CKD; eGFR 
45–59=stage 3a; eGFR 30–44=stage 3b; eGFR 15–29=stage 
4; eGFR <15=stage 5. Baseline CKD status was derived 
from eGFR measurements in the year prior to start of 
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follow-up by: (1) taking the last two measurements before 
the index date ≥90 days apart—with the higher eGFR 
value corresponding to the CKD baseline status or (2) 
taking the most recent serum creatinine result if only one 
suitable test result was available. Since serum creatinine is 
more likely to be tested in the acutely unwell or in people 
who are routinely monitored as part of incentivised 
programmes (eg, people with diabetes), patients without 
measurements of CKD baseline status were assumed to 
have no CKD27 and were analysed as such.
statistical analysis
Though propensity score matching was employed to 
minimise confounding, we compared the distribution of 
baseline characteristics between the exposed and unex-
posed groups to check for any imbalances that may be 
relevant to the outcome of AKI. The baseline distribu-
tion of categorical variables was analysed using percent-
ages and χ2 tests. Continuous variables were analysed as 
means with SD for normally distributed variables and 
medians with IQR for non-normally distributed variables. 
Differences in continuous variables were analysed with 
Student’s t-tests or Wilcoxon rank-sum tests for normally 
and non-normally distributed data, respectively.
The association between bariatric surgery and AKI was 
analysed using a Poisson regression model with a time to 
first event analysis. P values were calculated using Wald 
tests. In order to separate short-term effects of the surgery 
from potential long-term effects, we analysed the associa-
tion separately for: (1) events within the first 30 days and 
(2) events after 30 days. When the cohort was initially 
constructed, propensity score matching was used to deal 
with confounding.7 This study uses a subset of this cohort 
since patients from practices without linkage between the 
CPRD and HES databases had to be excluded (as AKI was 
assessed using hospital admission data). To identify vari-
ables for the multivariable model, potential confounders 
that were not deemed to be on the causal pathway were 
added individually to the univariable model. If the addi-
tion changed the effect estimate ≥10% these variables 
were included in the multivariable model. Consequently, 
history of AKI, history of taking oral antidiabetics and 
BMI at baseline were included (online supplementary 
appendix S2). In addition, age at baseline, sex, calendar 
period (1997–2005, 2006–2010, 2011–2015) and CKD 
status at baseline were selected a priori as forced vari-
ables. For models with <40 outcomes, only age and sex 
were included in the multivariable model due to data 
sparsity.
The 5% bands of patients with the highest and lowest 
propensity scores were excluded from the primary anal-
ysis (‘trimming’) since these contain patients who are 
treated in stark contrast to their health status, potentially 
causing bias.28
Heterogeneity of effect estimates between the calendar 
periods was tested with a Likelihood Ratio Test.
The analysis was performed for all patients with bariatric 
surgery and also further stratified by type of surgery. 
Patients with stage 5 CKD (baseline eGFR <15 mL/
min/1.73 m2) were excluded from the analyses since this 
constitutes end-stage renal disease. In addition, patients 
with missing data in ≥1 variable of the multivariable 
model were excluded from both univariable and multi-
variable analyses.
All analyses were performed with Stata V.14.1.
subgroup analyses
Several planned sensitivity analyses were undertaken: (1) 
To determine the net effect of the intervention we calcu-
lated the risk of AKI over the whole period of follow-up; 
(2) The prevalence of decreased kidney function in the 
CPRD database was similar to that in a nationally represen-
tative kidney disease registry27 indicating that patients with 
missing eGFR measurements are unlikely to have CKD. 
To identify potential differences in the effect between 
patients with known and unknown eGFR measurements, 
we restricted the analysis to (a) patients known to have no 
CKD at baseline (baseline eGFR ≥60 mL/min/1.73 m2), 
(b) patients without known CKD at baseline (as above but 
including patients with missing creatinine values at base-
line and assuming these individuals to have no CKD) and 
(c) patients with known CKD at baseline.27 (3) Moreover, 
to investigate the effect in a group of particular interest 
which is under more scrutiny for measuring kidney func-
tion we restricted the analysis to patients with: (a) T2DM 
and (b) a history of taking insulin; (4) To avoid misclassi-
fication of low eGFR values as AKI,29 we excluded patients 
with stage 4 CKD at baseline; (5) We restricted the anal-
ysis to ICD-10 codes N17.0 and N17.9, which have a high 
positive predictive value for AKI24; (6) We increased the 
immediate postsurgery time span from 30 to 60 days; 
(7) We included people with extreme propensity scores 
and (8) We excluded patients with a BMI <35 kg/m² at 
baseline.
results
Since linkage to the HES database was only possible for 
patients whose general practitioners (GPs) had agreed 
for their practice data to be linked to HES (online supple-
mentary appendix S3), there were 2643 patients with 
bariatric surgery and 2595 people without surgery 
resulting in a cohort of overall 5238 people with a median 
follow-up of 2.9 years (table 1). The median follow-up 
prior to baseline was similar between the groups: 8.8 years 
(IQR: 8.1 years) for patients with bariatric surgery and 9.3 
years (IQR: 8.0 years) for people without surgery.
This cohort was comparable with the cohort from 
the original study regarding sex, mean age, mean BMI, 
history of T2DM, type of bariatric surgery and the imbal-
ance of BMI at baseline.7 More patients in the inter-
vention group had a history of AKI compared with the 
comparison group (1.1% vs 0.4%). Of the 106 included 
events during follow-up, 84.9% were classified with the 
ICD-10 code N17.9 (‘acute kidney failure, unspecified’), 
12.3% were coded as N19 (‘unspecified kidney failure’) 
and 2.8% had a code of N17.0 (‘acute kidney failure with 
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Table 1 Baseline data for CPRD/HES-linked cohort study of people with bariatric surgery and the corresponding propensity 
score-matched* comparison cohort (data are n (%) unless otherwise specified)
Bariatric surgery
(n=2643)
Matched comparison group 
without surgery
(n=2595) P values†
Follow-up (years), median (IQR) 2.9 (3.2) 2.9 (3.4) 0.616
Age (years), mean (SD) 45.2 (10.7) 45.0 (10.8) 0.417
  17–39, n (%) 818 (31.0) 826 (31.8) 0.727
  40–49, n (%) 945 (35.8) 928 (35.8)
  50–85, n (%) 880 (33.3) 841 (32.4)
BMI at baseline, mean (SD) 44.9 (8.9) 42.2 (6.5) <0.001
  13–34, n (%) 297 (11.2) 287 (11.1) <0.001
  35–39, n (%) 448 (17.0) 456 (17.6)
  40–44, n (%) 625 (23.7) 1118 (43.1)
  45–49, n (%) 571 (21.6) 438 (16.9)
  50–94, n (%) 667 (25.2) 253 (9.8)
  Missing, n (%) 35 (1.3) 43 (1.7)
Female 2131 (80.6) 2131 (82.1) 0.166
History of
Cerebrovascular disease 37 (1.4) 26 (1.0) 0.186
Coronary heart disease 104 (3.9) 82 (3.2) 0.130
Peripheral vascular disease 11 (0.4) 15 (0.6) 0.405
Other atheroma 0 <5‡ 0.313
T2DM 900 (34.1) 853 (32.9) 0.365
Taking oral antidiabetic 571 (21.6) 455 (17.5) <0.001
Taking insulin 180 (6.8) 156 (6.0) 0.238
Hypertension 890 (33.7) 869 (33.5) 0.886
Statin use 699 (26.4) 640 (24.7) 0.139
AKI 30 (1.1) 11 (0.4) 0.003
Alcohol status
  Non-drinker 435 (16.5) 397 (15.3) 0.366
  Ex-drinker 278 (10.5) 236 (9.1)
  Current drinker (amount unknown) 15 (0.6) 13 (0.5)
  <2 units/day 659 (24.9) 644 (24.8)
  3–6 units/day 862 (32.6) 909 (35.0)
  >6 units/day 170 (6.4) 164 (6.3)
  Unknown 224 (8.5) 232 (8.9)
Smoking status
  Non-smoker 1126 (42.6) 1151 (44.4) 0.093
  Current smoker 403 (15.3) 345 (13.3)
  Ex-smoker 1112 (42.1) 1099 (42.4)
  Unknown <5‡ 0
CKD at baseline
  Baseline CKD status absent 1119 (42.3) 1299 (50.1) <0.001
  No CKD 1470 (55.6) 1242 (47.9)
  Stage 3a 27 (1.0) 37 (1.4)
  Stage 3b 16 (0.6) 10 (0.4)
  Stage 4 10 (0.4) 5 (0.2)
  Stage 5 <5‡ <5‡
Continued
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tubular necrosis’). CKD status at baseline was unknown 
for about half of the patients in each group with a slightly 
higher proportion in the unexposed group (50.1% vs 
42.3%). The majority of the patients with creatinine tests 
at baseline did not have CKD (96.2%).
The number of AKI events recorded in the first 30 days 
of follow-up was low. All five events happened in patients 
with bariatric surgery and none were recorded in the 
control group, which is consistent with the possibility of 
an increased risk of AKI directly after surgery (table 2).
From 30 days onwards, bariatric surgery had a protec-
tive association with AKI risk (crude rate ratio (RR) 0.62, 
95% CI 0.40 to 0.95). The effect estimate of the multivari-
able model indicated an even stronger protective effect 
associated with bariatric surgery (RR 0.37, 95% CI 0.23 to 
0.61), largely due to the confounding by AKI prior to 
baseline.
The analysis by type of surgery yielded protective effect 
estimates for all types but the CIs were wide and no 
comparison between individual procedures was feasible. 
Sensitivity analyses yielded similar results (online supple-
mentary appendix S4). A sensitivity analysis restricted 
to patients with known CKD at baseline could not be 
done owing to sparse data. Investigation of the effect of 
bariatric surgery over the whole follow-up period resulted 
in a protective net effect associated with the intervention 
in univariable (RR 0.71, 95% CI 0.47 to 1.07) and multi-
variable (RR 0.45, 95% CI 0.28 to 0.72) analyses.
DIsCussIOn
In this study using prospectively recorded routine health-
care data from a representative sample in the UK, bariatric 
surgery was associated with a potentially increased risk 
of AKI within the first 30 days after surgery (five events 
in patients with bariatric surgery, no events in control 
patients) but a strongly protective association thereafter 
(adjusted RR 0.37, 95% CI 0.23 to 0.61). The association 
was consistent across subgroups and sensitivity analyses. 
To the best of our knowledge, this is the first study to 
describe long-term effects of bariatric surgery on AKI.
AKI has been described as a perioperative event for 
bariatric surgery.12 13 15 16 Our results are consistent with 
an increased risk in the early stages after surgery, however, 
our analysis lacked enough early events to rule out chance 
as a reason for the results observed. Since patients do not 
have kidney function measures routinely checked by their 
family physician after bariatric surgery, many events could 
remain unnoticed. Patients with known CKD are more 
thoroughly checked for AKI and are a valuable subgroup 
to investigate, but the numbers in this dataset were too 
low to analyse.
This study uses high-quality data from routine medical 
care in the UK. The healthcare system allows universal 
patient access to primary and secondary care so that the 
data are representative of the population. Patients are 
followed continuously while they are registered with a GP 
allowing prospective data capture over long observation 
periods and avoiding problems with reverse causality.
Some limitations need to be considered. Even though 
the data are taken from a representative sample of the UK 
population, the baseline data indicate that patients who 
undergo bariatric surgery are mostly female, of middle 
age and with a history of T2DM. While the results were 
adjusted for age and sex, they might not be applicable 
Bariatric surgery
(n=2643)
Matched comparison group 
without surgery
(n=2595) P values†
Type of bariatric surgery
  Gastric band 1193 (45.1)
  Sleeve gastrectomy 364 (13.8)
  Gastric bypass 1075 (40.7)
  Other 11 (0.4)
ICD-10 code for AKI during follow-up n=44 n=62
  N17.0 (acute kidney failure with 
tubular necrosis)
<5‡ <5‡ 0.927
  N17.9 (acute kidney failure, 
unspecified)
38 (86.4) 52 (83.9)
  N19 (unspecified kidney failure) 5 (11.4) 8 (12.9)
*In the original study, each surgery patient was matched 1:1 to the person without surgery with the closest propensity score, 
choosing matches at random where more than one possible match had the same score.7
†Categorical variables: χ2 test; continuous variables: Student's t-test+SD if normally distributed, Wilcoxon rank-sum test+IQR if non-
normally distributed.
‡Cell counts <5 have been suppressed to ensure anonymity.
AKI, acute kidney injury; BMI, body mass index; CKD, chronic kidney disease; CPRD, Clinical Practice Research Datalink; HES, 
Hospital Episodes Statistics; ICD-10, International Classification of Diseases, 10th Revision; T2DM, type 2 diabetes mellitus.
Table 1 Continued 
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for other groups suffering from obesity like adolescents. 
Linkage between the CPRD and HES databases was 
restricted to England. However, there is no cogent reason 
why the results should not be applicable to regions with 
similar healthcare systems, both in the UK and interna-
tionally. We had insufficient data to determine whether 
the association with AKI varied between different types of 
bariatric surgery; we found a protective effect for gastric 
band, but results were inconclusive for sleeve gastrectomy 
and gastric bypass.
Of all AKI episodes identified in the HES database, 
the ICD-10 codes N17.0 and N17.9 comprised 87.7% of 
all events and have previously been shown to accurately 
identify AKI in a single-centre study.24 However, there are 
no ICD-10 codes for grades of AKI severity. Thus, we were 
not able to investigate whether there was an association 
between bariatric surgery and AKI severity. In general, 
AKI diagnosed during hospitalisation is likely to repre-
sent more serious AKI events and therefore may underes-
timate AKI incidence. Thus, the conclusions drawn from 
this study may only be applicable to severe AKI diagnosed 
during hospitalisation, however, we would argue these are 
the most clinically relevant outcomes. Moreover, a patient 
who experienced a previous AKI episode might be under 
more scrutiny for detection of future episodes. Since 
more patients in the bariatric surgery group had a history 
Table 2 Association of bariatric surgery with first incident AKI, stratified by length of follow-up
PY Events
Rate per 1000 PY 
(95% CI)
Crude RR
(95% CI)* P values†
Adjusted RR
(95% CI)‡ P values†
All patients
Day 1–30
  Unexposed 203 0 0 –
  Bariatric surgery 199 5 25.1 (10.5 to 60.4) – 
>Day 30
  Unexposed 7882 54 6.9 (5.2 to 8.9) – 
  Bariatric surgery 8061 34 4.2 (3.0 to 5.9) 0.62 
(0.40 to 0.95)
0.027 0.37 
(0.23 to 0.61)
<0.001
All patients analysed by type of surgery§
Day 1–30
  Unexposed
  Gastric band
  Sleeve gastrectomy
  Gastric bypass
  Other
>Day 30
  Unexposed 7882 54 6.9 (5.2 to 8.9) – 
  Gastric band 4614 17 3.7 (2.3 to 5.9) 0.54 
(0.31 to 0.93)
0.026
  Sleeve gastrectomy 728 <5¶ 5.5 (2.1 to 14.6) 0.80 
(0.29 to 2.21)
0.670
  Gastric bypass 2655 13 4.9 (2.8 to 8.4) 0.71 
(0.39 to 1.31)
0.277
  Other 63 0 – – 
All patients over whole period of follow-up
  Unexposed 8085 54 6.7 (5.1 to 8.7) – 
  Bariatric surgery 8259 39 4.7 (3.5 to 6.5) 0.71 
(0.47 to 1.07)
0.099 0.45 
(0.28 to 0.72)
0.001
Unexposed refers to the propensity-matched comparison group. 
*Poisson regression model.
†Wald test.
‡Poisson regression model adjusted for age at baseline, sex, calendar time, CKD at baseline, history of AKI, history of taking oral 
antidiabetics and BMI at baseline.
§No analysis for day 1–30 owing to sparse data.
¶Cell counts <5 have been suppressed to ensure anonymity.
AKI, acute kidney injury; BMI, body mass index; CKD, chronic kidney disease; PY, person years; RR, rate ratio.
 o
n
 22 M
ay 2018 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2017-020371 on 16 May 2018. Downloaded from 
7Koppe U, et al. BMJ Open 2018;8:e020371. doi:10.1136/bmjopen-2017-020371
Open Access
of AKI they might have a higher chance of detection of 
an AKI episode during follow-up, which we adjusted for 
in our analyses.
Misclassification of diagnostic codes is likely non-dif-
ferential between the bariatric surgery patients and the 
matched comparison group and would bias the effect 
towards the null value. However, it is also conceivable 
during the immediate postoperative period those under-
going bariatric surgery might have been under more scru-
tiny to detect potential AKI events than people without 
surgery. In this case, our current relative risk estimates for 
the immediate postoperative period would be an overes-
timate. Another problem of primary care data is that not 
every patient is routinely checked for their kidney func-
tion, as incentives of testing apply primarily for those at 
risk of kidney disease due to diabetes and hypertension. 
The study relied on AKI events recorded in HES as part of 
a hospital admission and over time, the awareness of the 
importance of AKI has likely changed resulting in secular 
changes in recording of AKI23; analyses have adjusted for 
calendar period to account for this.23 30 Future studies 
with hospital creatinine data should compare the AKI 
severity between the groups to investigate this issue.
In addition, CKD status at baseline was missing in 
almost half of the patient population. However, a recent 
study indicated that the prevalence of CKD in the CPRD 
database was comparable to that found in nationally 
representative registry studies.27 This indicates that 
patients without a GP record of eGFR measurements at 
baseline are unlikely to have CKD. In addition, sensitivity 
analyses investigating the effect in patients with known 
or unknown CKD status at baseline yielded comparable 
results.
Since access to bariatric surgery is restricted within the 
UK healthcare system, some patients might have funded 
their operation privately, resulting in selection bias. In a 
recent analysis about 40% of bariatric surgery operations 
in the UK were privately funded.31 Thus, the intervention 
group might have a higher socioeconomic status than the 
non-exposed group, in which similar patients would not 
be able to afford surgery. Since the socioeconomic back-
ground is an important determinant of health outcomes 
and was an unmeasured potential confounder not consid-
ered in the matching process, this could have led to more 
positive health outcomes in the intervention group irre-
spective of surgery and to an overestimation of the effect. 
In this study setting, it was not possible to determine 
which patients had privately funded surgery.
Even though most baseline variables were evenly 
distributed due to the matching process, this does not 
guarantee that unmeasured variables are evenly distrib-
uted as well, which can constitute residual confounding. 
Incorrect, imprecise or missing measurements of covari-
ates could also have led to residual confounding. For the 
multivariable model, adjusting for history of AKI led to 
the strongest change of the effect estimate. AKI events are 
likely under-recorded in the HES database, for reasons 
described above, and thus residual confounding is 
possible. Since adjusting for AKI history led to a stronger 
effect estimate, the protective effect we report here may 
be an underestimate if AKI history is missing to the same 
degree in surgery and non-surgery patients.
This study adds to the evidence of long-term effects of 
bariatric surgery, and appears to be the first study to quan-
tify a long-term beneficial effect on AKI. Future studies 
with higher patient numbers may be able to determine 
differences in effect between types of surgery, investigate 
the effect in patients with CKD and elucidate mechanisms 
of the association between bariatric surgery and AKI.
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